Science & Research

Viral Infections Significantly Increase Heart Attack and Stroke Risk, Study Finds

Viral Infections Significantly Increase Heart Attack and Stroke Risk, Study Finds

New research reveals that both acute infections like influenza and COVID-19 and chronic viral infections including HIV and hepatitis C substantially elevate cardiovascular disease risks, highlighting the importance of preventive measures including vaccination.

October 29, 2025
New Book Examines Lasting Impact of War of the Worlds Broadcast 87 Years Later

New Book Examines Lasting Impact of War of the Worlds Broadcast 87 Years Later

William Elliott Hazelgrove's new book 'Dead Air' explores how Orson Welles' 1938 radio drama created America's first viral media event, revealing important lessons about media influence and mass psychology that remain relevant today.

October 29, 2025
Medical Cannabis Access Linked to Reduced Opioid Use Among Cancer Surgery Patients

Medical Cannabis Access Linked to Reduced Opioid Use Among Cancer Surgery Patients

A new study reveals that states with medical cannabis dispensaries show decreased opioid prescriptions for cancer surgery patients but increased non-treatment hospital visits, highlighting the complex implications of cannabis policy on pain management and healthcare utilization.

October 28, 2025
Glioblastoma Remission Rates Remain Challenging Despite Treatment Advances

Glioblastoma Remission Rates Remain Challenging Despite Treatment Advances

Only 25% of glioblastoma patients experience remission lasting at least two years, highlighting the urgent need for improved treatments for this aggressive brain cancer.

October 28, 2025
Oncotelic's Nanomedicine Platform Advances Cancer Treatment Through Enhanced Drug Delivery

Oncotelic's Nanomedicine Platform Advances Cancer Treatment Through Enhanced Drug Delivery

Oncotelic Therapeutics' Deciparticle platform represents a significant advancement in nanomedicine that improves drug bioavailability and therapeutic effectiveness in oncology treatments.

October 28, 2025
Quantumzyme Showcases Sustainable Pharmaceutical Innovation at Global Enzyme Engineering Conference

Quantumzyme Showcases Sustainable Pharmaceutical Innovation at Global Enzyme Engineering Conference

Quantumzyme Corp.'s participation in the Enzyme Engineering XXVIII Conference highlights the company's advancements in eco-friendly pharmaceutical manufacturing through computational enzyme engineering.

October 28, 2025
New IDSA Guidelines Highlight Critical Need for Tailored COVID-19 Vaccines for Immunocompromised Population

New IDSA Guidelines Highlight Critical Need for Tailored COVID-19 Vaccines for Immunocompromised Population

GeoVax's GEO-CM04S1 vaccine addresses the significant protection gap for over 40 million immunocompromised Americans who experience limited effectiveness from current COVID-19 vaccines, as highlighted by new Infectious Diseases Society of America guidelines.

October 28, 2025
Circadian Rhythm Disruptions Linked to Increased Cardiometabolic Disease Risk, American Heart Association Warns

Circadian Rhythm Disruptions Linked to Increased Cardiometabolic Disease Risk, American Heart Association Warns

The American Heart Association's new scientific statement reveals that disruptions to the body's internal clock significantly increase risks for obesity, Type 2 diabetes, high blood pressure and cardiovascular disease, highlighting the importance of circadian alignment for preventive health strategies.

October 28, 2025
Dr. Hos Loftus Earns 2025 Castle Connolly Top Doctor Recognition for Integrated Neurology and Psychology Care

Dr. Hos Loftus Earns 2025 Castle Connolly Top Doctor Recognition for Integrated Neurology and Psychology Care

Dr. Hos Loftus has been recognized as a 2025 Castle Connolly Top Doctor for his innovative integrated approach to neurological and psychological care at Carolinas Institute for Neurology and Psychology, highlighting the growing importance of holistic treatment models in modern healthcare.

October 28, 2025
Octane's 2025 Medical Innovation Forum to Spotlight Health Longevity Breakthroughs

Octane's 2025 Medical Innovation Forum to Spotlight Health Longevity Breakthroughs

Southern California's premier innovation accelerator Octane will host its 2025 Medical Innovation Forum featuring groundbreaking longevity research and wellness innovations that could transform future healthcare approaches.

October 27, 2025
Space Robotics Workers Selects Spacedock Interface for Orbital Assembly Systems

Space Robotics Workers Selects Spacedock Interface for Orbital Assembly Systems

Space Robotics Workers has chosen Spacedock's intelligent interface technology to enable autonomous assembly and maintenance of orbital infrastructure, representing a significant advancement toward scalable space operations and sustainable space ecosystems.

October 27, 2025
MAX Power Mining Expands Natural Hydrogen Exploration with New Saskatchewan Target

MAX Power Mining Expands Natural Hydrogen Exploration with New Saskatchewan Target

MAX Power Mining has identified the Bracken target as its first high-priority Natural Hydrogen drilling location beyond the Genesis Trend in Saskatchewan, advancing Canada's position in the emerging natural hydrogen sector.

October 27, 2025
Nanomedicine Breakthroughs Transform Cancer Drug Delivery and Bioavailability

Nanomedicine Breakthroughs Transform Cancer Drug Delivery and Bioavailability

Recent advancements in nanomedicine technology are revolutionizing oncology treatment by improving drug delivery systems, enhancing bioavailability, and potentially transforming underperforming cancer drugs into effective therapies through platforms like Oncotelic Therapeutics' Deciparticle.

October 27, 2025
Study Reveals Chemotherapy May Damage Brain's Waste Drainage System, Explaining 'Chemo Brain' Symptoms

Study Reveals Chemotherapy May Damage Brain's Waste Drainage System, Explaining 'Chemo Brain' Symptoms

New research identifies chemotherapy-induced damage to the brain's waste drainage network as a potential cause of cognitive difficulties affecting up to 75% of cancer patients during and after treatment.

October 27, 2025
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic

Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic

Aditxt's subsidiary Pearsanta has begun enrolling patients in a clinical study for a novel blood-based endometriosis test that could provide earlier, non-invasive detection compared to current surgical methods.

October 27, 2025
NanoViricides to Present Antiviral Pipeline Updates at PODD 2025 Conference

NanoViricides to Present Antiviral Pipeline Updates at PODD 2025 Conference

NanoViricides will showcase its broad-spectrum antiviral drug platform at the upcoming PODD 2025 conference, highlighting progress toward Phase II trials for its lead candidate NV-387 targeting multiple respiratory viruses and MPox.

October 27, 2025
Annovis Bio Secures $3.4 Million in Registered Direct Offering to Advance Neurodegenerative Disease Therapies

Annovis Bio Secures $3.4 Million in Registered Direct Offering to Advance Neurodegenerative Disease Therapies

Annovis Bio has raised $3.4 million through a registered direct offering to fund development of treatments for Alzheimer's and Parkinson's diseases, providing crucial capital for advancing late-stage clinical programs targeting neurodegeneration.

October 27, 2025
KAILASA Launches 121 AI Agents to Bridge Ancient Hindu Wisdom with Modern Global Challenges

KAILASA Launches 121 AI Agents to Bridge Ancient Hindu Wisdom with Modern Global Challenges

KAILASA has unveiled 121 specialized AI agents designed to make ancient Hindu scriptures and sciences accessible for addressing contemporary global issues including sustainable development, AI ethics, and scientific research.

October 25, 2025
New LED Therapy Shows Promise in Targeting Cancer Cells While Preserving Healthy Tissues

New LED Therapy Shows Promise in Targeting Cancer Cells While Preserving Healthy Tissues

Researchers have developed a novel LED-based cancer treatment that selectively destroys cancer cells while minimizing damage to healthy tissues, potentially offering a more precise alternative to conventional therapies like chemotherapy and radiation.

October 24, 2025
MAX Power Mining to Drill Canada's First Dedicated Natural Hydrogen Well in 2025

MAX Power Mining to Drill Canada's First Dedicated Natural Hydrogen Well in 2025

MAX Power Mining is advancing North America's first dedicated natural hydrogen drilling program, positioning the company to potentially unlock a new clean energy source that could transform industrial power and data center operations across the continent.

October 24, 2025
Soligenix's HyBryte Shows Promise as Potential First-Line Treatment for Cutaneous T-Cell Lymphoma

Soligenix's HyBryte Shows Promise as Potential First-Line Treatment for Cutaneous T-Cell Lymphoma

Soligenix Inc. is advancing HyBryte as a potential first-line therapy for early-stage cutaneous T-cell lymphoma following promising results from clinical trials that could reshape treatment standards in the rare disease space.

October 24, 2025
D-Wave Quantum Expands European Presence With €10M Quantum Computing Initiative in Italy

D-Wave Quantum Expands European Presence With €10M Quantum Computing Initiative in Italy

D-Wave Quantum Inc. is establishing Italy as a quantum innovation hub through a €10 million contract for quantum computing access and educational seminars as part of the Q-Alliance initiative.

October 24, 2025
MAX Power Mining Receives License for Canada's First Dedicated Natural Hydrogen Well

MAX Power Mining Receives License for Canada's First Dedicated Natural Hydrogen Well

MAX Power Mining has secured the drilling license for Canada's inaugural dedicated natural hydrogen well in Saskatchewan, marking a significant advancement in the country's clean energy transition and positioning the company as a pioneer in this emerging sector.

October 24, 2025
Chinese Surgical Innovations Transform Treatment for Previously Inoperable Liver Conditions

Chinese Surgical Innovations Transform Treatment for Previously Inoperable Liver Conditions

Advanced extracorporeal liver surgery techniques developed in China are providing new hope for patients with complex liver tumors and parasitic diseases previously considered surgically untreatable, eliminating the need for donor organs and lifelong immunosuppression.

October 24, 2025
New Novel 'Hidden in Plain Sight' Explores Intersection of Science, Mystery and Human Resilience

New Novel 'Hidden in Plain Sight' Explores Intersection of Science, Mystery and Human Resilience

Author Irv Selman's new novel Hidden in Plain Sight combines science fiction with profound human themes of grief and resilience while exploring humanity's search for meaning in the cosmos.

October 24, 2025
New Melanoma Test Shows Three-Fold Improvement in Predicting Lymph Node Metastasis Risk

New Melanoma Test Shows Three-Fold Improvement in Predicting Lymph Node Metastasis Risk

The Merlin CP-GEP test accurately stratifies melanoma patients by sentinel node metastasis risk, potentially reducing unnecessary surgical procedures through improved personalized care.

October 24, 2025
Xuemo's Literary Works Spark Global Dialogue on Human Spirit in AI Era at Frankfurt Book Fair

Xuemo's Literary Works Spark Global Dialogue on Human Spirit in AI Era at Frankfurt Book Fair

Award-winning writer Xuemo's literature emerged as a central focus at the 2025 Frankfurt Book Fair, sparking international discussions about maintaining human wisdom and compassion amid rapid technological advancement.

October 23, 2025
Updated Pediatric and Neonatal CPR Guidelines Emphasize Unique Needs of Children

Updated Pediatric and Neonatal CPR Guidelines Emphasize Unique Needs of Children

The American Heart Association and American Academy of Pediatrics have released updated CPR and emergency cardiovascular care guidelines that provide specific recommendations for infants and children, addressing the approximately 27,000 pediatric cardiac arrests occurring annually in the United States.

October 23, 2025
Oncotelic Therapeutics Announces Three Abstracts on Deciparticle Everolimus Accepted for 2025 San Antonio Breast Cancer Symposium

Oncotelic Therapeutics Announces Three Abstracts on Deciparticle Everolimus Accepted for 2025 San Antonio Breast Cancer Symposium

Oncotelic Therapeutics will present three abstracts on its investigational intravenous Deciparticle everolimus at the 2025 San Antonio Breast Cancer Symposium, highlighting potential improvements over existing mTOR inhibitors for metastatic breast cancer treatment.

October 23, 2025
NanoViricides Reports NV-387 Shows Strong Antiviral Activity Against Measles in Preclinical Studies

NanoViricides Reports NV-387 Shows Strong Antiviral Activity Against Measles in Preclinical Studies

NanoViricides' clinical lead drug candidate NV-387 demonstrated potent antiviral effects against Measles virus with significant lung protection and extended survival in animal models, potentially offering the first approved treatment for a disease that currently has no specific antiviral therapy.

October 23, 2025
PreviousPage 12 of 38Next